Weekly movers: Hits and misses in the large cap space during the week!

Weekly movers: Hits and misses in the large-cap space during the week!

Indian Market
by 5paisa Research Team Last Updated: 2022-12-23T15:51:04+05:30

Here’s a list of the top 5 gainers and losers this week in the large-cap space.

In the last 5 trading sessions, the frontline index S&P BSE Sensex plunged by 0.83 %, going from the level of 61,337.81 on December 16 to 60,826.22 on December 22. Similarly, the NIFTY declined by 0.78 %, going from 18,269 on December 16 to 18,127.35 on December 22. 

Let us have a look at the top gainers and losers in the large-cap space during the last 5 trading sessions (between December 16 and December 22).

Top 5 Gainers  

Return (%)  

General Insurance Corporation of India  

5.49  

Lupin Ltd.  

5.35  

Divi's Laboratories Ltd.  

5.2  

Max Healthcare Institute Ltd.  

4.96  

Apollo Hospitals Enterprise Ltd.  

4.7  

  

Top 5 Losers  

Return (%)  

Adani Wilmar Ltd.  

-13.34  

Yes Bank Ltd.  

-10.61  

Adani Power Ltd.  

-10.45  

UCO Bank  

-10.16  

Union Bank Of India  

-9.98  

 

  

General Insurance Corporation of India-

The shares of General Insurance Corporation of India surged by 5.5% in the last 5 trading sessions. This surge came in the backdrop of a board meeting which was scheduled on December 21, 2022, to consider and approve general matters of the Corporation. Apart from this, General Insurance Corporation of India has not made any significant announcements of late. Hence, the rally in the share price could be driven by the market forces.

Lupin Ltd- 

On Wednesday, the company announced the launch of its Regional Reference Laboratory in Indore, Madhya Pradesh, as part of its expansion in Central India. On the same day, the company reported that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Brivaracetam Tablets in the following strengths- 10 mg, 25 mg, 50 mg, 75 mg and 100 mg. The Brivaracetam Tablets are a generic equivalent of Briviact Tablets, available in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg and are produced by UCB Inc. Today, the company reported a spurt in trading volume by more than 4.59 times.

Divi's Laboratories Ltd-

In the last 5 trading sessions, the shares of Divi's Laboratories Ltd gained by 5.2 %. It should be noted that Divi's Laboratories Ltd has not made any significant announcements of late. Hence, the rally in the share price could be driven by the market forces. Today, the company reported a spurt in trading volume by more than 5.58 times.


Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Disclaimer

Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.

Open Free Demat Account

& get benefits worth 2100*

Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code
Account belongs to

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number